无症状颈动脉狭窄:内膜剥脱术较支架置入术卒中与死亡更低
该系统综述与荟萃分析纳入9项随机对照试验共3709例无症状颈动脉狭窄患者,比较颈动脉内膜剥脱术(CEA)与颈动脉支架置入术(CAS)。结果显示CAS组30天卒中或死亡率和卒中率均显著高于CEA组,但颅神经损伤显著更低,心肌梗死无显著差异;长期卒中或死亡加同侧卒中仍以CEA更优。
要点
- 无症状颈动脉狭窄患者CAS组30天卒中或死亡率2.94%,CEA组1.89%。
- CAS组30天颅神经损伤0.11%,显著低于CEA组3.21%。
- CAS组30天心肌梗死0.66%,CEA组1.50%,差异无统计学意义。
核心结论
- 在无症状颈动脉狭窄接受颈动脉干预的患者中,中等质量证据提示CEA的30天卒中及卒中或死亡率显著低于CAS。
- CEA以更高的颅神经损伤率和无统计学意义更高的心肌梗死率为代价。
- CEA在随访期间的同侧卒中预防长期疗效(计入围手术期卒中与死亡)得以保持。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Scopus数据库截至2017年3月17日,无时间限制。
- 纳入9项随机对照试验,共3709例患者,CEA组1479例,CAS组2230例。
- 采用Peto比值比(OR)及95%置信区间(CI)进行荟萃分析,并用GRADE方法评估证据质量。
主要发现
- 30天卒中或死亡率CAS组64/2176(2.94%)显著高于CEA组27/1431(1.89%),OR 1.57,95%CI 1.01-2.44,P=.044,I2=0%。
- 30天卒中率CAS组63/2176(2.90%)显著高于CEA组26/1431(1.82%),OR 1.63,95%CI 1.04-2.54,P=.032,I2=0%。
- 30天心肌梗死CAS组12/1815(0.66%)低于CEA组16/1070(1.50%),OR 0.53,95%CI 0.24-1.14,P=.105,I2=0%。
- 30天颅神经损伤CAS组2/1794(0.11%)显著低于CEA组33/1061(3.21%),OR 0.13,95%CI 0.07-0.26,P<.00001,I2=0%。
- 30天卒中或死亡加随访期同侧卒中CAS组79/2173(3.64%)显著高于CEA组35/1430(2.45%),OR 1.51,95%CI 1.02-2.24,P=.04,I2=0%。
关键数值与推荐
- 所有卒中结局的证据质量评为中等。
- 原文指出在做出CAS不劣于或劣于CEA的明确推荐前,迫切需要高质量研究。
临床怎么用
- 对无症状颈动脉狭窄患者选择血运重建方式时,可将CEA作为30天卒中及卒中或死亡风险更低的选项。
- CAS颅神经损伤风险显著更低,但需权衡其较高的30天卒中及卒中或死亡风险。
- CAS与CEA的30天心肌梗死差异无统计学意义,决策时应结合个体风险综合判断。
局限性
- 所有卒中结局的证据质量仅为中等。
- 原文指出在做出CAS与CEA优劣的明确推荐前,迫切需要高质量研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is currently unclear if carotid artery stenting (CAS) is as safe as carotid endarterectomy (CEA) for patients with significant asymptomatic stenosis. The aim of our study was to perform a systematic review and meta-analysis of trials comparing CAS with CEA. METHODS: On March 17, 2017, a search for randomized controlled trials was performed in MEDLINE and Scopus databases with no time limits. We performed meta-analyses with Peto odds ratios (ORs) and 95% confidence intervals (CIs). Quality of evidence was assessed with the Grading of Recommendations Assessment, Development, and Evaluation method. The primary safety and efficacy outcome measures were stroke or death rate at 30 days and ipsilateral stroke at 1 year (including ipsilateral stroke and death rate at 30 days), respectively. Perioperative stroke, ipsilateral stroke, myocardial infarction (MI), and cranial nerve injury (CNI) were all secondary outcome measures. RESULTS: The systematic review of the literature identified nine randomized controlled trials reporting on 3709 patients allocated into CEA (n = 1479) or CAS (n = 2230). Stroke or death rate at 30 days was significantly higher for CAS (64/2176 [2.94%]) compared with CEA (27/1431 [1.89%]; OR, 1.57; 95% CI, 1.01-2.44; P = .044), with low level of heterogeneity beyond chance (I2 = 0%). Also, stroke rate at 30 days was significantly higher for CAS (63/2176 [2.90%]) than for CEA (26/1431 [1.82%]; OR, 1.63; 95% CI, 1.04-2.54; P = .032; I2 = 0%). MI at 30 days was nonsignificantly lower for CAS (12/1815 [0.66%]) compared with CEA (16/1070 [1.50%]; OR, 0.53; 95% CI, 0.24-1.14; P = .105; I2 = 0%); however, CNI at 30 days was significantly lower for CAS (2/1794 [0.11%]) than for CEA (33/1061 [3.21%]; OR, 0.13; 95% CI, 0.07-0.26; P < .00001; I2 = 0%). Regarding the long-term outcome of stroke or death rate at 30 days plus ipsilateral stroke during follow-up, this was significantly higher for CAS (79/2173 [3.64%]) than for CEA (35/1430 [2.45%]; OR, 1.51; 95% CI, 1.02-2.24; P = .04; I2 = 0%). Quality of evidence for all stroke outcomes was graded moderate. CONCLUSIONS: Among patients with asymptomatic stenosis undergoing carotid intervention, there is moderate-quality evidence to suggest that CEA had significantly lower 30-day stroke and also stroke or death rates compared with CAS at the cost of higher CNI and nonsignificantly higher MI rates. The long-term efficacy of CEA in ipsilateral stroke prevention, taking into account perioperative stroke and death, was preserved during follow-up. There is an urgent need for high-quality research before a firm recommendation is made that CAS is inferior or not to CEA.
引用
- Kakkos SK, Kakisis I, Tsolakis IA, et al. Endarterectomy achieves lower stroke and death rates compared with stenting in patients with asymptomatic carotid stenosis. J Vasc Surg. 2017. PMID: 28735954. doi:10.1016/j.jvs.2017.04.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。